Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines
The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry
President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism
The California Department of Managed Health Care Extends the Phase-In Period for the General Licensure Regulation
Telehealth and Online Prescribing: COVID-19 Triggers Changes to the Prescriber/Patient/Pharmacist Relationship
Blogs